141 related articles for article (PubMed ID: 37920449)
21. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
22. A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.
Xu J; Gao Y; Hu S; Li S; Wang W; Wu Y; Su Z; Zhou X; Cheng X; Zheng Q
Ann Clin Biochem; 2021 Sep; 58(5):434-444. PubMed ID: 33827266
[TBL] [Abstract][Full Text] [Related]
23. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
[TBL] [Abstract][Full Text] [Related]
24. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
[TBL] [Abstract][Full Text] [Related]
25. Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.
Hu J; Zhou J; Dong F; Tan J; Wang S; Li Z; Zhang X; Zhang H; Ming J; Huang T
Medicine (Baltimore); 2020 Oct; 99(42):e22774. PubMed ID: 33080747
[TBL] [Abstract][Full Text] [Related]
26. Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease.
Kojima K; Yoon H; Okishio K; Tsuyuguchi K
Sci Rep; 2023 Jan; 13(1):1012. PubMed ID: 36653462
[TBL] [Abstract][Full Text] [Related]
27. Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection.
Fisher SA; Goldstein JA; Mithal LB; Isaia AL; Shanes ED; Otero S; Miller ES
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100458. PubMed ID: 34403821
[TBL] [Abstract][Full Text] [Related]
28. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
[TBL] [Abstract][Full Text] [Related]
29. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.
Vidal-Cevallos P; Higuera-De-La-Tijera F; Chávez-Tapia NC; Sanchez-Giron F; Cerda-Reyes E; Rosales-Salyano VH; Servin-Caamaño A; Vázquez-Medina MU; Méndez-Sánchez N
Ann Hepatol; 2021; 24():100338. PubMed ID: 33647501
[TBL] [Abstract][Full Text] [Related]
30. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
31. All-cause mortality in moderate and severe COVID-19 patients with myocardial injury receiving versus not receiving azvudine: a propensity score-matched analysis.
Chen R; Guo Y; Deng S; Wang J; Gao M; Han H; Wang L; Jiang H; Huang K
Cardiol Plus; 2023; 8(2):103-110. PubMed ID: 37539021
[TBL] [Abstract][Full Text] [Related]
32. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.
Li C; Ye J; Chen Q; Hu W; Wang L; Fan Y; Lu Z; Chen J; Chen Z; Chen S; Tong J; Xiao W; Mei J; Lu H
Aging (Albany NY); 2020 Aug; 12(15):15670-15681. PubMed ID: 32805722
[TBL] [Abstract][Full Text] [Related]
33. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
34. Azvudine for the Treatment of COVID-19 in Pre-Existing Cardiovascular Diseases: A Single-Center, Real-World Experience.
Wu L; He ZH; Huang L; Guo X; Li XY; Zhang HD; Chen MH
Adv Sci (Weinh); 2024 Mar; ():e2306050. PubMed ID: 38544344
[TBL] [Abstract][Full Text] [Related]
35. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study.
Shi J; Li Y; Zhou X; Zhang Q; Ye X; Wu Z; Jiang X; Yu H; Shao L; Ai JW; Zhang H; Xu B; Sun F; Zhang W
BMC Med; 2020 Jun; 18(1):168. PubMed ID: 32493370
[TBL] [Abstract][Full Text] [Related]
36. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
37. Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
Sepulchre E; Pittie G; Stojkovic V; Haesbroek G; Crama Y; Schyns M; Paridaens H; de Marchin J; Degesves S; Biemar C; Boccar S; Senterre JM; Minon JM
Acta Clin Belg; 2022 Apr; 77(2):261-267. PubMed ID: 32935644
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19.
Barrett B; Pamphile S; Yang F; Naeem F; Kim J; Annam J; Borczuk R; Yellin S; Bass C; Fowler S; Mosheyev M; Mayer YJ; Friedman BW
Am J Emerg Med; 2021 Aug; 46():595-598. PubMed ID: 33280969
[TBL] [Abstract][Full Text] [Related]
39. Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study.
Russo A; Pisaturo M; De Luca I; Schettino F; Maggi P; Numis FG; Gentile I; Sangiovanni V; Rossomando AM; Gentile V; Calabria G; Rescigno C; Megna AS; Masullo A; Manzillo E; Russo G; Parrella R; Dell'Aquila G; Gambardella M; Ponticiello A; Reginelli A; Coppola N;
J Infect Public Health; 2023 Jan; 16(1):136-142. PubMed ID: 36521329
[TBL] [Abstract][Full Text] [Related]
40. High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients.
Alcántara-Alonso E; Molinar-Ramos F; González-López JA; Alcántara-Alonso V; Muñoz-Pérez MA; Lozano-Nuevo JJ; Benítez-Maldonado DR; Mendoza-Portillo E
Clin Nutr ESPEN; 2021 Aug; 44():437-444. PubMed ID: 34330502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
